BioCardia, Inc.
BCDA
$2.23
-$0.02-0.89%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.39M | -7.95M | -7.72M | -8.56M | -10.34M |
| Total Depreciation and Amortization | 60.00K | 67.00K | 72.00K | 77.00K | 81.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.05M | 1.05M | 1.06M | 1.14M | 1.29M |
| Change in Net Operating Assets | -829.00K | -1.19M | -710.00K | 241.00K | 18.00K |
| Cash from Operations | -8.11M | -8.03M | -7.30M | -7.11M | -8.94M |
| Capital Expenditure | -6.00K | -6.00K | -5.00K | -3.00K | -2.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -6.00K | -6.00K | -5.00K | -3.00K | -2.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 9.30M | 10.55M | 11.86M | 4.75M | 5.61M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.18M | -1.25M | -1.46M | -529.00K | -572.00K |
| Cash from Financing | 8.12M | 9.30M | 10.40M | 4.22M | 5.04M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00 | 1.27M | 3.10M | -2.88M | -3.91M |